Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereof

3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereof

US Patent 12268700 · Granted Apr 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Purification and labeling of extracellular vesicles using a mixed mode resin com2024
Fungal modulators2023
Molecular nanotags2022
Compositions and methods for the treatment of HER2-expressing solid tumors2022
Compositions and methods for the treatment of HER2-expressing solid tumors2022
Optical configuration methods for spectral scatter flow cytometry2020
Multi-epitope TARP peptide vaccine and uses thereof2019
Multi-epitope TARP peptide vaccine and uses thereof2019
Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunity2016
Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunity2016
Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and he2016
Immunostimulatory combinations of TLR ligands and methods of use2016